Literature DB >> 9374795

The imidazoline receptor in control of blood pressure by clonidine and allied drugs.

D J Reis1, J E Piletz.   

Abstract

Clonidine, moxonidine, and rilmenidine are centrally acting antihypertensive agents that lower arterial pressure by inhibiting the tonic activity of sympathoexcitatory neurons in the rostral ventrolateral medulla. Competing hypotheses have been put forward by different investigators to explain the sympathoinhibition evoked by "imidazoline drugs": either via central actions at alpha 2-adrenergic receptors or novel I1-imidazoline receptors. These different perspectives are presented in the accompanying reviews.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374795     DOI: 10.1152/ajpregu.1997.273.5.R1569

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Noradrenergic modulation of risk/reward decision making.

Authors:  David R Montes; Colin M Stopper; Stan B Floresco
Journal:  Psychopharmacology (Berl)       Date:  2015-03-13       Impact factor: 4.530

2.  Moxonidine for tramadol withdrawal symptoms during detoxification.

Authors:  Farid Talih; Elias Ghossoub
Journal:  BMJ Case Rep       Date:  2015-07-08

Review 3.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 4.  Brain stem adenosine receptors modulate centrally mediated hypotensive responses in conscious rats: A review.

Authors:  Noha N Nassar; Abdel A Abdel-Rahman
Journal:  J Adv Res       Date:  2014-12-18       Impact factor: 10.479

5.  Agmatine modulates spontaneous activity in neurons of the rat medial habenular complex-a relevant mechanism in the pathophysiology and treatment of depression?

Authors:  Torsten Weiss; René Bernard; Hans-Gert Bernstein; Rüdiger W Veh; Gregor Laube
Journal:  Transl Psychiatry       Date:  2018-09-24       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.